Figure 1. Prostate cancer cells recruit more mast cells after the treatment with casodex or enzalutamide (MDV3100).

A. Mast cell recruitment capabilities were assayed using LNCaP and C4-2 cells conditioned media (CM) treated with 10 μM casodex or 10 μM MDV3100. B. Quantification data for mast cell migration. Results were presented as the mean ± SEM. Statistical analysis was done by two-tailed Student's t test, * p < 0.05.